Micronization of Tiotropium Bromide via Gas Jet Milling
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for preparing micronized tiotropium bromide for inhalation face challenges in achieving a stable, anhydrous form that maintains pharmacological properties during the grinding process, which is crucial for effective treatment of asthma and COPD.
Innovation Solution
A process involving the comminution of tiotropium bromide monohydrate in a gas jet mill using a fluidized powder bed, resulting in a virtually anhydrous form with specific particle size and water content, achieved through controlled grinding pressure, nozzle size, and screening wheel speed, ensuring minimal degradation and enhanced stability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Length of moving object
If tiotropium bromide is ground using conventional methods to achieve micronized form, then particle size is reduced to required range, but the active substance degrades and loses stability
Solution Approach 1:
The patent replaces conventional mechanical grinding systems with a fluid energy mill that uses high-velocity gas jets to comminute particles. This substitution of mechanical contact with gas-phase energy transfer reduces degradation of the active substance while achieving the required micronized particle size distribution.
Solution Approach 2:
The patent changes the physical parameters of the grinding process by controlling gas pressure, gas flow rate, and residence time in the fluid energy mill. These parameter adjustments enable achievement of target particle size while maintaining the stability of tiotropium bromide through optimized process conditions.
2Reliability
If tiotropium bromide monohydrate is processed to remove water, then anhydrous form is achieved improving stability, but additional processing steps are required
Solution Approach 1:
The patent performs preliminary dehydration of tiotropium bromide monohydrate before the comminution process. By removing water content in advance, the subsequent grinding process operates on anhydrous material that exhibits improved stability and reduced caking, eliminating the need for additional drying steps after micronization.
Solution Approach 2:
The patent combines the dehydration and comminution operations into an integrated process flow where the fluid energy mill simultaneously handles both the dried material processing and particle size reduction, reducing overall process complexity compared to separate sequential operations.
3Ease of operation
If conventional grinding methods are used, then equipment is simple and easy to operate, but the active substance undergoes unwanted changes affecting pharmacological properties
Solution Approach 1:
The patent replaces mechanical grinding equipment with a fluid energy mill system that uses controlled gas jets for particle comminution. This substitution eliminates mechanical contact that causes degradation while maintaining operational simplicity through automated gas flow and pressure control systems.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The process effectively produces a stable, virtually anhydrous micronized tiotropium bromide with improved chemical and physicochemical stability, suitable for inhalable powders, enhancing therapeutic efficacy in treating respiratory conditions like asthma and COPD.
Implementation Method 1
the tiotropium bromide monohydrate particles are comminuted in a fluidised powder bed
Data Source
AI summary
The invention relates to a method for producing a micronized, virtually anhydrous form of (1α,2β,4β,5α,7β)-7-[(hydroxydi-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane bromide, said form per se, and the use thereof for producing a medicament, especially a medicament having an anticholinergic effect.